Blue was chosen because most rescue inhalers are short-acting beta-agonists ... Blue, for example, can mean the inhaler is for quick symptom relief. Every time you use an inhaler for asthma, COPD, or ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... based rescue medicine to be cleared ...

Current albuterol rescue inhalers alleviate acute symptoms ... system for asthma and chronic obstructive pulmonary disease (COPD) in the US, with the first patients signed up to the wheezo ...

ABC News’ Linsey Davis spoke to the widow of Dennoriss Richardson, who was found hanging in an abandoned Alabama house last September.

Long‐acting muscarinic antagonists (LAMAs) are a class of long-acting bronchodilators initially developed to treat COPD. They may be prescribed ... Quick-relief medications, also called short-term ...

While most research has focused on general air pollution, emerging studies indicate that wildfire smoke can have similar ...

Background Exacerbations of chronic obstructive pulmonary disease (COPD) are characterised by increased dyspnoea ... Seventy-two percent of all participants were prescribed a combination of inhaled ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.